AstraZeneca Falls On Downgrade In Rating
Shares of AstraZeneca Plc (NYSE: AZN) moved down in pre-market trading after Royal Bank of Scotland downgraded the company.
RBS downgraded AZN from “buy” to “hold.” The broker said, "AstraZeneca had a strong run of positive news flow over the summer and the near-term share price drivers have played out. AstraZeneca is within 10% of our target price and we lower our recommendation to hold."
AZN shares dropped 0.88% to $51.56 in pre-market trading.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Royal Bank of ScotlandAnalyst Color Downgrades Markets Analyst Ratings
